185 related articles for article (PubMed ID: 27875414)
21. Effect of Surgery on Quality of Life of Patients with Spinal Metastasis from Non-Small-Cell Lung Cancer.
Tang Y; Qu J; Wu J; Liu H; Chu T; Xiao J; Zhou Y
J Bone Joint Surg Am; 2016 Mar; 98(5):396-402. PubMed ID: 26935462
[TBL] [Abstract][Full Text] [Related]
22. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
Cicenas S; Zaliene A; Atkocius V
Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
[TBL] [Abstract][Full Text] [Related]
23. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems.
Wibmer C; Leithner A; Hofmann G; Clar H; Kapitan M; Berghold A; Windhager R
Spine (Phila Pa 1976); 2011 Nov; 36(23):1977-86. PubMed ID: 21304424
[TBL] [Abstract][Full Text] [Related]
24. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Nomura Y
Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
[TBL] [Abstract][Full Text] [Related]
25. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
Paralkar VR; Li T; Langer CJ
Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
[TBL] [Abstract][Full Text] [Related]
26. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
Kudelin N; Bölükbas S; Schirren J
Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
[TBL] [Abstract][Full Text] [Related]
27. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with improved survival following surgical treatment for metastatic prostate cancer in the spine: retrospective analysis of 29 patients in a single center.
Meng T; Chen R; Zhong N; Fan T; Li B; Yin H; Li Z; Zhou W; Song D; Xiao J
World J Surg Oncol; 2016 Jul; 14(1):200. PubMed ID: 27472919
[TBL] [Abstract][Full Text] [Related]
29. Implication of Biomarker Mutations for Predicting Survival in Patients With Metastatic Lung Cancer to the Spine.
Choi BD; Shankar GM; Sivaganesan A; Van Beaver LA; Oh K; Shin JH
Spine (Phila Pa 1976); 2018 Nov; 43(21):E1274-E1280. PubMed ID: 29652780
[TBL] [Abstract][Full Text] [Related]
30. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes following total en bloc spondylectomy for spinal metastases from lung cancer.
Kato S; Demura S; Kitagawa R; Yokogawa N; Shimizu T; Kobayashi M; Yamada Y; Nagatani S; Murakami H; Kawahara N; Tsuchiya H
J Orthop Sci; 2024 May; 29(3):908-913. PubMed ID: 37149482
[TBL] [Abstract][Full Text] [Related]
32. Establishment and validation of a novel survival prediction scoring algorithm for patients with non-small-cell lung cancer spinal metastasis.
Zang S; He Q; Bao Q; Shen Y; Zhang W
Int J Clin Oncol; 2019 Sep; 24(9):1049-1060. PubMed ID: 31028506
[TBL] [Abstract][Full Text] [Related]
33. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
34. Functional outcomes and survival after surgical stabilization for inoperable non-small-cell lung cancer with spinal metastasis of the thoracic and lumbar spines: a retrospective comparison between epidermal growth factor receptor-tyrosine kinase inhibitor and platinum-based chemotherapy groups.
Lin HH; Chiu CH; Chou PH; Ma HL; Wang JP; Wang ST; Liu CL; Chang MC
Spinal Cord; 2020 Feb; 58(2):194-202. PubMed ID: 31501501
[TBL] [Abstract][Full Text] [Related]
35. Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology.
Zakaria HM; Llaniguez JT; Telemi E; Chuang M; Abouelleil M; Wilkinson B; Chandra A; Boyce-Fappiano D; Elibe E; Schultz L; Siddiqui F; Griffith B; Kalkanis SN; Lee IY; Chang V
Neurosurgery; 2020 May; 86(5):705-716. PubMed ID: 31232439
[TBL] [Abstract][Full Text] [Related]
36. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
37. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
[TBL] [Abstract][Full Text] [Related]
38. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
[TBL] [Abstract][Full Text] [Related]
39. [Prognosis after surgical treatment of spinal metastases due to lung cancer].
Hessler C; Regelsberger J; Raimund F; Heese O; Madert J; Eggers C
Chirurg; 2008 Jul; 79(7):671-9. PubMed ID: 18496656
[TBL] [Abstract][Full Text] [Related]
40. Application of morphometric analysis to patients with lung cancer metastasis to the spine: a clinical study.
Zakaria HM; Basheer A; Boyce-Fappiano D; Elibe E; Schultz L; Lee I; Siddiqui F; Griffith B; Chang V
Neurosurg Focus; 2016 Aug; 41(2):E12. PubMed ID: 27476836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
